1,856
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Transforming the prostatic tumor microenvironment with oncolytic virotherapy

, , , , , , , , , , , , , , , , , & ORCID Icon show all
Article: e1445459 | Received 20 Feb 2018, Accepted 21 Feb 2018, Published online: 27 Mar 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jonathan G Pol, Matthew J Atherton, Byram W Bridle, Kyle B Stephenson, Fabrice Le Boeuf, Jeff L Hummel, Chantal G Martin, Julia Pomoransky, Caroline J Breitbach, Jean-Simon Diallo, David F Stojdl, John C Bell, Yonghong Wan & Brian D Lichty. (2018) Development and applications of oncolytic Maraba virus vaccines. Oncolytic Virotherapy 7, pages 117-128.
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now

Articles from other publishers (20)

Yixin Jin, Kristina Berg Lorvik, Yang Jin, Carole Beck, Adam Sike, Irene Persiconi, Emilie Kvaløy, Fahri Saatcioglu, Claire Dunn & Jon Amund Kyte. (2022) Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer. Molecular Therapy - Oncolytics 26, pages 189-206.
Crossref
Dankun Luo, Haiwei Wang, Qiang Wang, Wenping Liang, Bo Liu, Dongbo Xue, Yang Yang & Biao Ma. (2022) Senecavirus A as an Oncolytic Virus: Prospects, Challenges and Development Directions. Frontiers in Oncology 12.
Crossref
Robert S. Foti. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 716 742 .
Krishna Das, Elodie Belnoue, Matteo Rossi, Tamara Hofer, Sarah Danklmaier, Tobias Nolden, Liesa-Marie Schreiber, Katharina Angerer, Janine Kimpel, Sandra Hoegler, Bart Spiesschaert, Lukas Kenner, Dorothee von Laer, Knut Elbers, Madiha Derouazi & Guido Wollmann. (2021) A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity. Nature Communications 12:1.
Crossref
Amanda W. K. AuYeung, Robert C. Mould, Ashley A. Stegelmeier, Jacob P. van Vloten, Khalil Karimi, J. Paul Woods, James J. Petrik, Geoffrey A. Wood & Byram W. Bridle. (2021) Mechanisms that allow vaccination against an oncolytic vesicular stomatitis virus-encoded transgene to enhance safety without abrogating oncolysis. Scientific Reports 11:1.
Crossref
Linpei Guo, Hui Xie, Zheng Zhang, Zhun Wang, Shuanghe Peng, Yuanjie Niu & Zhiqun Shang. (2021) Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer. Vaccines 9:7, pages 786.
Crossref
Erkko Ylösmäki & Vincenzo Cerullo. (2020) Design and application of oncolytic viruses for cancer immunotherapy. Current Opinion in Biotechnology 65, pages 25-36.
Crossref
Jonathan G Pol, Matthew J Atherton, Kyle B Stephenson, Byram W Bridle, Samuel T Workenhe, Natasha Kazdhan, AJ Robert McGray, Yonghong Wan, Guido Kroemer & Brian D Lichty. (2020) Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning. Journal for ImmunoTherapy of Cancer 8:2, pages e000981.
Crossref
Christianne Groeneveldt, Thorbald van Hall, Sjoerd H. van der Burg, Peter ten Dijke & Nadine van Montfoort. (2020) Immunotherapeutic Potential of TGF-β Inhibition and Oncolytic Viruses. Trends in Immunology 41:5, pages 406-420.
Crossref
Lizhi Li, Shixin Liu, Duoduo Han, Bin Tang & Jian Ma. (2020) Delivery and Biosafety of Oncolytic Virotherapy. Frontiers in Oncology 10.
Crossref
Elena Busch, Kristina D. Kubon, Johanna K. M. Mayer, Gemma Pidelaserra-Martí, Jessica Albert, Birgit Hoyler, Johannes P. W. Heidbuechel, Kyle B. Stephenson, Brian D. Lichty, Wolfram Osen, Stefan B. Eichmüller, Dirk Jäger, Guy Ungerechts & Christine E. Engeland. (2020) Measles Vaccines Designed for Enhanced CD8+ T Cell Activation. Viruses 12:2, pages 242.
Crossref
Lorenzo Galluzzi & Nils-Petter Rudqvist. 2020. Tumor Immunology and Immunotherapy – Integrated Methods Part B. Tumor Immunology and Immunotherapy – Integrated Methods Part B xvii xxxvi .
Lorenzo Galluzzi & Nils-Petter Rudqvist. 2020. Tumor Immunology and Immunotherapy – Integrated Methods Part A. Tumor Immunology and Immunotherapy – Integrated Methods Part A xix xxxviii .
Lorenzo Galluzzi & Nils-Petter Rudqvist. 2020. Tumor Immunology and Immunotherapy – Cellular Methods Part B. Tumor Immunology and Immunotherapy – Cellular Methods Part B xxiii xlii .
Lorenzo Galluzzi & Nils-Petter Rudqvist. 2020. Tumor Immunology and Immunotherapy – Cellular Methods Part A. Tumor Immunology and Immunotherapy – Cellular Methods Part A xxiii xlii .
Caroline J. Breitbach. 2020. Oncolytic Viruses. Oncolytic Viruses 285 293 .
Jonathan G. Pol, Byram W. Bridle & Brian D. Lichty. 2020. Oncolytic Viruses. Oncolytic Viruses 191 211 .
Amanda Rosewell Shaw & Masataka Suzuki. (2019) Immunology of Adenoviral Vectors in Cancer Therapy. Molecular Therapy - Methods & Clinical Development 15, pages 418-429.
Crossref
Cole Peters, Paola Grandi & Fares Nigim. (2019) Updates on Oncolytic Virus Immunotherapy for Cancers. Molecular Therapy - Oncolytics 12, pages 259-262.
Crossref
Lorenzo Galluzzi & Nils-Petter Rudqvist. 2019. Tumor Immunology and Immunotherapy – Molecular Methods. Tumor Immunology and Immunotherapy – Molecular Methods xxi xl .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.